BeiGene, Ltd. declared today that the U.S. Food and Drug Administration has accepted its Biologics License Application for TEVIMBRA® combined with fluoropyrimidine- and platinum-containing

Genmab A/S and AbbVie have jointly announced that the U.S. Food and Drug Administration has given Priority Review status to their supplemental Biologics License Application

XYRA LLC, a private biopharmaceutical company focused on developing innovative therapies for cardiac rhythm disorders, is pleased to announce an agreement with the FDA regarding the next steps for its drug

Curi Bio, a leader in developing human stem cell-based platforms for drug discovery, has announced a Memorandum of Understanding for scientific collaboration with Genetox and DreamCIS

Alpha Cognition Inc, also known as Alpha Cognition, a biopharmaceutical company focused on developing novel treatments for severe neurodegenerative disorders, is excited to announce the submission of a new

MRM Health, a biopharmaceutical company in the clinical stage, has received approval from regulatory and ethics committees to commence an observational cross-sectional clinical trial. This trial aims to identify specific microbial and metabolic patterns

Disc Medicine, Inc, a biopharmaceutical company focusing on innovative treatments for severe hematologic diseases, has announced that the United States Food and Drug Administration

AffaMed Therapeutics, a prominent biotechnology company specializing in developing and commercializing innovative pharmaceutical and surgical products for unmet needs in ophthalmology

Certa Therapeutics, a biotechnology company specializing in precision therapies for inflammatory and fibrotic diseases, has announced that the U.S. Food and Drug Administration has granted Fast Track Designation for its investigational therapy

Iovance Biotherapeutics, Inc, a biotechnology company focused on developing novel polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients, has received approval from the U.S. Food and Drug Administration